456
We rely on the capital markets for the growth of our brands.

Elevai Labs Inc. Announces Name Change to PMGC Holdings Inc. and Redomicile to Nevada...

Elevai Labs Inc. Announces Anticipated Name Change to PMGC Holdings Inc. and Redomicile to Nevada...

Elevai Labs Inc. Announces Withdrawal of Offer to Exchange and Plans to Reassess...

Elevai Labs Inc. Reports Financial Results for the Third Fiscal Quarter of 2024 and Provides Busines...

Elevai Labs Inc. Announces Update and Extension of Pending Offer to Exchange...

Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Engages Leading Contract Research Organization...

Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Highlights Past Positive Preclinical Data Show...

Elevai Labs Inc. Commences Offer to Exchange Up to 15,000,000 shares of Common Stock For Shares of N...

Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Expands Patent Portfolio with Two New Filings ...

Elevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Launch of Clinical Study Combining Its ...

Elevai Labs Inc. Announces Pricing of $8.0 Million Public Offering...

Elevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Positive Results for E-Series Exosome T...

Elevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Encouraging Data Results Indicating Pot...

Elevai Labs Inc. Files Combination Patents with Yuva Biosciences for Breakthrough Hair and Scalp Car...

Elevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Positive Data Results with Completion o...

Elevai Labs Inc. Subsidiary, Elevai Research Inc., Announces Preliminary Positive Research Data High...

Elevai Labs Inc. Reports Second Quarter 2024 Financial Results and Provides Business Update...

Elevai Labs Inc. Subsidiary, Elevai Biosciences, Continues to Advance its Scientific Advisory Board ...

Elevai Labs Inc. Subsidiary, Elevai Skincare, Announces The Elevai S-Series Hair and Scalp Care Prod...

Elevai Labs Inc. Subsidiary, Elevai Skincare to Debut Upcoming New Product Line at The Aesthetic Sho...

Elevai Labs Forms New Scientific Advisory Board for its Weight Loss Programs...

Elevai Labs Subsidiary, Elevai Skincare, to Present at the Beauty Through Science Conference in Stoc...

Elevai Labs Inc Subsidiary, Elevai Biosciences, to Present at the UCLA LA-BEST 2024 Conference...

Elevai Labs Inc. Reports First Quarter 2024 Financial Results...

Elevai Biosciences Highlights Preclinical Data Showing Potential of In-Licensed Asset “EL-22” fo...

Elevai Labs Expands with Launch of Elevai Biosciences and Elevai Skincare Subsidiaries, Advancing th...

Elevai Labs Acquires Exclusive License to Two Myostatin Muscle Loss Prevention Assets with Plan to D...

Elevai Labs Highlights Global Distribution Partnership Overview: Contracts May Secure $4.9M Top Line...

ELEVAI Labs Enters the Taiwan Market with Signing of 5th International Distribution Agreement in 14 ...

Elevai Labs Inc. Reports Record Full Year 2023 and Fourth Quarter Financial Results...

Elevai Labs Launches E-commerce Portal to Support Rapid Growth as Stem Cell Exosome Disruptor in the...

ELEVAI Labs Inc. Announces Issuance of Patent from U.S. Patent & Trademark Office...

ELEVAI LABS, Inc. Reports Strong Preliminary Unaudited Financial Performance for Fiscal Year 2023, H...

ELEVAI Labs, Inc. Acquires Worldwide License Agreement for Proprietary Stem Cell Manufacturing Techn...

ELEVAI LABS, Inc. to Participate in Upcoming Aesthetic Industry Conferences...